Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Randomized Open Comparison of Oxtellar XR® vs Oxcarbazepine IR (Trileptal®) for the Treatment of Bipolar Depression

NCT03567681 is registered in ClinicalTrials.gov with Collaborative Care Initiative, LLC as lead sponsor.

NCT NCT03567681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03567681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Randomized Open Comparison of Oxtellar XR® vs Oxcarbazepine IR (Trileptal®) for the Treatment of Bipolar Depression
Lead sponsor
Collaborative Care Initiative, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
June 13, 2018
Completion date
September 30, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, measure-based guidance, treatment effectiveness